G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 97 filers reported holding G1 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $32,522 | -16.6% | 12,135 | +137.1% | 0.00% | – |
| Q1 2022 | $39,000 | -25.0% | 5,118 | 0.0% | 0.00% | – |
| Q4 2021 | $52,000 | -24.6% | 5,118 | 0.0% | 0.00% | – |
| Q3 2021 | $69,000 | -38.4% | 5,118 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $112,000 | -8.9% | 5,118 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $123,000 | +33.7% | 5,118 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $92,000 | +178.8% | 5,118 | +80.2% | 0.00% | – |
| Q3 2020 | $33,000 | -52.2% | 2,840 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $69,000 | +475.0% | 2,840 | +158.4% | 0.00% | – |
| Q1 2020 | $12,000 | -58.6% | 1,099 | 0.0% | 0.00% | – |
| Q4 2019 | $29,000 | +16.0% | 1,099 | 0.0% | 0.00% | – |
| Q3 2019 | $25,000 | -26.5% | 1,099 | 0.0% | 0.00% | – |
| Q2 2019 | $34,000 | +88.9% | 1,099 | 0.0% | 0.00% | – |
| Q1 2019 | $18,000 | -14.3% | 1,099 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -12.5% | 1,099 | +134.8% | 0.00% | – |
| Q3 2018 | $24,000 | – | 468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |